Inspire sleep apnea horror stories and bad reviews: what is behind them, and what can be fixed

Inspire sleep apnea horror stories and bad reviews are hard to weigh on their own, so this page starts from published data: what support groups and reports to the FDA describe, what is behind each problem, and what can be fixed. In a study of support-group posts, pain and uncomfortable stimulation came up most often, and both usually improve with time or new settings. About one in three patients in the pivotal trial did not meet its definition of success. Some problems cannot be fixed, and for some people a different treatment was the better choice.

On this page
  1. What bad reviews describe
  2. How to read Inspire reviews
  3. Problems, causes and fixes
  4. If Inspire isn’t working
  5. How often serious problems happen
  6. Pros and cons
  7. Could it have been predicted?
  8. Questions to ask your surgeon
  9. Common questions
  10. References

The short answer. In the pivotal trial behind its FDA approval, about two out of three patients met the trial’s definition of success at one year, and about one in three did not.[1] When my research group studied a year of posts in three Inspire support groups on Facebook, the problems people described most often were pain and uncomfortable stimulation; infection came up less often than in FDA reports, possibly because people describe it as swelling or warmth rather than by name.[2]

When the implant is not working, the usual first steps are a closer look at how it is used and new settings, not another operation. When it is the wrong treatment for someone’s airway or goals, that is best found before surgery.

What do Inspire bad reviews and horror stories describe?

The published data point to a consistent set of problems. In my group’s study of support-group posts, pain, uncomfortable stimulation, lip and tongue weakness and a tight wire in the neck led the list.[2] Reports to the FDA add infection, collections of blood or fluid, parts that moved or malfunctioned, and overstimulation.[3] A disappointing result is a separate matter, measured in trials rather than posts: about one in three patients in the pivotal trial did not meet the success definition at one year.[1] Each of these problems has a usual cause, and many can be improved.

What my research group found in online support groups

In 2024 we published a study of the posts made over one year, from October 2022 to October 2023, in three Facebook groups for people who have Inspire or are considering it. Across 737 posts, we counted 132 reported problems. Pain made up about a third of those problems (35%), uncomfortable stimulation about one in seven (14%), lower-lip weakness 7%, tongue weakness 5%, a tight wire in the neck 4%, and scarring 3%.[2]

We compared those posts with the reports filed with the FDA over the same year. People in the groups described lip weakness and the tight neck wire more often than the FDA reports did, which suggests the FDA database undercounts both; both are part of the conversation I have with every patient before surgery. They described infection less often, possibly because people tend to write about swelling, redness or warmth rather than use the word infection.[2] One of the three groups exists to report problems, so the posts lean toward problems.

What the FDA’s device-report database shows

The FDA’s MAUDE database collects reports of problems with medical devices. It is a passive reporting system: it records problems that someone chose to report, and it cannot show how many people had none.[4] In my group’s analysis of every report about these implants filed from 2014 to 2023, 1,178 reports described 1,312 problems. About a quarter of the reported problems were infections, one in five involved pain, and one in ten was a collection of blood or fluid under the skin. Most of the reported problems needed some treatment, and removing or repositioning the device were the most frequent procedures.[3] These are shares of the reports, not how often each problem happens; the rates are on my risks page.

Device faults and the 2024 recall

Any implanted electronic device can develop a fault, and Inspire is no exception; reports to the FDA include parts that moved, wore through the skin or malfunctioned.[3] The one Inspire recall the FDA has placed in its most serious category, Class I, began in May 2024: a possible manufacturing defect in 24 Inspire IV generators could cause electrical leakage in the generator’s sensing circuit, a malfunction that required surgery to replace the generator. The company’s notice asked surgeons to bring affected patients in for a device check of the stimulation signal, and to watch for changes in stimulation, therapy that stops working, or therapy that will not turn on.[5] Inspire’s other entries in the FDA recall database are Class II, for labeling errors on packaged parts.[5]

A few FDA reports also describe overstimulation during an MRI scan.[3] That is one reason to have any scan done under the conditions for your exact device model, and to show your Inspire ID card to the radiology team first.

A note on device versions. Everything above, the support-group posts, the FDA reports and the 2024 recall, comes from earlier versions of Inspire. In Inspire V, the current device, the breathing sensor is built into the generator. No sensing wire is placed between the ribs anymore, so problems specific to that wire no longer apply.[6] The part that does the treating has not changed: the lead on the nerve moves the tongue as before, and there is still a chest incision and a generator. Pain, stimulation comfort, lip and tongue weakness, the neck wire, infection and generator faults all carry over.

How should you read Inspire sleep apnea reviews?

As one source among several. People who have had a problem are more likely to post about it, and testimonials chosen by a manufacturer lean the other way. Neither shows you the person’s sleep study, airway exam, device settings, or how far along they were. A review written two weeks after the device was switched on describes a treatment that has not been set yet, because the strength is raised gradually over the first few months.

A single account can tell you what happened to one person. It cannot tell you how often that happens, which is the question that matters for your decision. The published studies have blind spots of their own: trials and registries come mostly from experienced, high-volume centers, and a database of reports has no denominator. That is why my group looked at patient groups in the first place. Each source catches problems the others miss.[2]

When you read an Inspire review, a few details tell you how much weight to give it:

  • How long after the device was switched on it was written.
  • Whether the person had a follow-up sleep study, and what kind.
  • Whether the problem was comfort, a side effect, the result, or the hardware. Each has a different fix.
  • Whether they went back to have the settings adjusted, and what happened then.

Problems with Inspire, their causes and their fixes

Most problems with Inspire fall into a few groups, and each has a usual cause and a usual fix. Discomfort is mostly a settings problem. A disappointing result is worked through in steps: more time, more hours of use, new settings, a look at the airway with the device on, and sometimes a second treatment. Hardware faults are fixed by replacing the part. The table pairs what people report with what is usually behind it and what usually helps.

What people describeWhat is often behind itWhat usually helps
Pain after surgerySoreness at the neck and chest incisions, which usually settles within one to two weeks. Pain that grows, with swelling, redness or warmth, can mean blood collecting under the skin or an infection.Time and simple pain relief. Fever of 100.4°F or higher, swelling that is excessive or keeps growing, or bleeding from an incision means a call to your surgeon’s office; my post-op instructions list the full set of warning signs.
Stimulation that is uncomfortable or wakes youA strength that is too high for now, an electrode setting that does not suit you (the setting chooses which contacts on the cuff deliver the pulse), or being awake while it runs: the pulses do not reliably keep in step with your breathing while you are awake.The pause button, a lower strength, or a different electrode setting. Reprogramming while the airway is watched with a small camera often lowers the strength needed.[7]
Still snoring, still tired, or a disappointing sleep studySettings not yet at a treating level, too few hours of use, a sleep study that measured something different from your whole night, or an airway that still closes at the palate even though the tongue moves forward.The step-by-step workup in the next section. In one series of 29 patients whose implant was not working, new settings or an added treatment turned eight of them into patients who met the success definition.[8]
Lower-lip or tongue weaknessLip: a stretch of the small nerve to the lower lip, which runs near the neck incision. Tongue: irritation of the tongue nerve itself, where the stimulation cuff is placed.Almost always improves with time. A lasting, usually subtle difference is possible.
A tight band in the neck when looking upThe wire that connects the neck and chest scarring to the tissue around it.Neck rolls in the first weeks after surgery help prevent it, and it usually eases. In some patients it is bothersome enough to lead to a second operation.
A sore tongueThe tongue rubbing on the lower teeth with each pulse.A settings change usually helps. Tell your team about a sore spot that does not heal.
Overstimulation, or a sudden change in the stimulationA hardware fault, a lead that has moved, or, rarely, an MRI scan; all appear in FDA reports.[3] The 2024 generator recall involved a fault that could change or stop stimulation.[5]Use the remote to pause the therapy or turn it down, and contact your implanting team so the device can be checked. A device check of the stimulation signal can find a faulty part, which is replaced in a revision operation.[5]

Rates for each of these, with sources, are in one table on my page about Inspire side effects and risks. Pain and neck-roll guidance follows my post-op instructions.

What if Inspire isn’t working for me?

Tell your implanting team, and expect a step-by-step workup rather than a verdict. Early on, the stimulation is set low on purpose and raised over weeks, so it is often too soon to judge. After that, the team checks how many hours you use it, whether the stimulation is comfortable, and how your sleep study was done. If the result is still short, the device is reprogrammed while the airway is watched, and if needed a second treatment is added. A second operation is rarely the first answer.

  1. Give the settings time. The device is turned on about four weeks after surgery at a low strength. You raise it in small steps, roughly weekly, as you tolerate it, and the first sleep study comes three to four months after surgery. My Inspire post-op instructions call this a marathon, not a sprint: some people feel better within weeks, while others need months to reach their best settings.
  2. Check how much it is used. The device records when it is on, and it treats only the hours it is running. In a study of the first three months of use in 2,098 patients, most used it more than six hours a night. The smaller groups who used it less had frequent missed nights or pauses, which the authors suggest may reflect discomfort, insomnia or sleep habits.[9]
  3. Make it comfortable. Comfort and results are connected. In a large registry, people who reported discomfort used the device less, about 4.9 hours a night against 5.7, and ended with more breathing events, an average of 18.9 an hour against 13.5.[10] A lower strength, a different electrode setting and the pause button usually help, and there are thousands of possible settings.
  4. Check how the result was measured. An in-lab titration study and an all-night home study can give very different answers in the same person. In one study of 61 patients tested both ways, 80% met the success definition on the in-lab titration study, against 46% on the all-night home study.[11] Before the implant is called a failure, it helps to know which kind of study produced the number and whether it was done at your current setting. I explain this in detail on my page about the Inspire success rate.
  5. Look at the airway with the device on. If the numbers are still short, the next step is to watch what the stimulation does. My post-op instructions describe an awake endoscopy in the office: a thin camera through the nose while the device is reprogrammed, to find the settings that open the airway best. At one center, 19 of 60 implant patients (32%) had at least one awake endoscopy to reprogram the device, most often for uncomfortable stimulation, waking at night, or ongoing tiredness or apnea; afterward, the stimulation strength needed fell by roughly half.[7] In my practice, when the first sleep study falls short, the usual next step is an awake endoscopy in the office: a small camera through the nose while we cycle through different settings to find the one that works best, followed by a repeat sleep study. Some centers instead repeat the drug-induced sleep endoscopy (DISE) under sedation with the device switched on, which shows the airway during sleep.[8]
  6. Add a second treatment when the airway still closes. Sometimes the tongue moves forward but the airway still closes somewhere else, most often at the soft palate. In a Dutch series of 29 patients whose implant was not working, sleep endoscopy with the device on showed that in 16 of 25, the palate did not move forward with the tongue. New settings were enough for some. Others added an oral appliance, palate surgery or other airway surgery, and eight more patients reached the definition of success.[8]
  7. Consider revision surgery when a part has failed or is in the wrong place. A second operation is worth considering for a generator that has developed a fault, a lead that has shifted or worked toward the skin, a cuff or lead that is not in the best position, or, rarely, a connecting wire that has scarred down tightly enough to need freeing. Hardware faults are covered in more detail under hardware problems on my risks page.

Falling short is not always the same as no benefit

In the ADHERE registry, 31% of 717 patients did not meet the success definition at one year, yet 77% of them reported a better quality of life, and many of them kept using the device. The authors’ advice was to keep using it when it helps and to add other treatment to close the gap.[12] Clinicians who wrote a post-implant care pathway for this therapy describe the same middle group, with results that are good but not great, as the patients for whom close follow-up and targeted changes matter most.[13]

Turning Inspire off, or taking it out

Turning it off takes a press of the remote; taking it out is a second operation. A review of 121 removals found that malfunction, infection and a part that had moved were the leading reasons, ahead of discomfort, and that problems after removal were uncommon.[14]

How often do serious problems with Inspire happen?

Not often. Serious complications are uncommon in the trial that led to approval, in the large registries and in my own center’s published series, and most problems people describe online settle with time or improve with adjustment. The exceptions that matter most are infection and hardware failure, because those can mean removing or replacing the device. Every rate, with its source and whether it still applies to the current device, is in one table on my risks page.

That page walks through each risk the way I discuss it before surgery, including how I try to prevent infection, a complication that often ends with the device being removed.

What are the pros and cons of Inspire?

The main advantages are that there is nothing to wear, it starts with a press of a button, and most people use it for most of the night. The drawbacks are an operation, months of adjustment, follow-up visits for as long as you have it, results that vary from person to person, and a battery that is changed in a shorter operation about every 10 to 11 years.

Pros

  • No mask, hose or machine, and nothing on your face.
  • Turned on and off with a small remote.
  • Most people used it more than six hours a night in the first three months.[9]
  • Adjustable after surgery: settings can be changed many times without another operation.
  • It can be turned off, or removed.
  • Serious complications are uncommon.

Cons

  • An operation, with two incisions and the risks that come with them.
  • Three to four months, sometimes longer, to reach its best settings.
  • About one in three patients in the pivotal trial did not meet the success definition at one year.[1]
  • A shorter operation to replace the battery about every 10 to 11 years.
  • MRI only under the conditions for your model.
  • Snoring usually improves, but there is no guarantee it stops.

If you are still weighing CPAP against an implant, my page on what it means to fail CPAP explains why I ask for a real CPAP effort first.

Could a bad outcome have been predicted?

Sometimes. Some bad outcomes trace back to a mismatch that can be found before surgery: a soft palate that collapses from all sides on sleep endoscopy, sleep apnea that is mostly central rather than obstructive, CPAP that has not had a real trial, higher weight, or the expectation of a guaranteed cure. Others are harder to foresee: every patient in the pivotal trial had met strict selection criteria, and about one in three still fell short of the success definition.[1] That is why the evaluation before surgery matters as much as the operation.

  • Higher weight. Success falls as BMI rises, even within the limits: in a large registry, 72% of patients with a BMI of 32 or less met the success definition against 60% of those between 32 and 35.[10] The FDA label goes up to 40; Medicare’s limit is under 35, and some plans set 32.
  • The goal is a guarantee. Results vary, adjustment takes months, and the device needs use every night and checks at least twice a year.

For some people the better fit is a different implant. Genio, which I also implant, works on the same nerve from both sides and has no implanted battery; how the two differ is laid out in Inspire vs Genio. For others it is palate surgery or continued work on CPAP. The full list, with each situation explained, is on my page about when Inspire isn’t the right choice.

What should you ask your surgeon before Inspire surgery?

Ask the questions that predict a smoother course: how experienced the surgeon and the team that programs the device are, what your sleep endoscopy showed, which sleep study will judge the result, and what happens if that result falls short. The plan for a disappointing result is best learned before surgery, not after it. Questions worth bringing:

  1. How many of these operations have you done, and who adjusts the device afterward? Experience with this particular operation matters for complications, and it was also the highest-rated factor, at 8.0 out of 10, among the 151 people who rated what mattered most when choosing an implant on this site.
  2. What did my sleep endoscopy show, and does it favor one implant over the other?
  3. Which sleep study will measure my result, and what will count as success?
  4. If my first sleep study is not good enough, what is the plan? Ask whether reprogramming with an awake endoscopy is available, and who does it.
  5. What do you do to lower the risk of infection?
  6. Which model will I receive, and what are its MRI conditions?
  7. Whom do I call if the stimulation hurts or I think the device has stopped working?

Common questions about Inspire problems

Does Inspire work for sleep apnea?

In the pivotal trial behind its FDA approval, two out of three patients met the trial’s definition of success at one year, and apnea events fell by about two-thirds. About one in three did not meet it, which is why results are checked with a sleep study a few months after surgery and the settings are adjusted when they fall short.

What are the most common complaints about Inspire?

In a published study of Inspire support groups online, the problems people described most were pain after surgery and uncomfortable stimulation, followed by weakness of the lower lip or tongue and a tight band in the neck. Most of those settle with time or improve with a settings change. Reports to the FDA also include infection, collections of blood or fluid, and parts that moved or malfunctioned.

What can be done if Inspire is not working?

First, the basics: how many hours it is used, whether the stimulation is comfortable, and how the result was measured. Then the device can be reprogrammed, often while the surgeon watches the airway through a thin camera in the office. If the tongue moves forward but the airway still closes, a second treatment such as an oral appliance or palate surgery can be added.

Can Inspire be removed?

Yes. It can be turned off at any time, or removed in a second operation. In a review of 121 removals, the most common reasons were a device malfunction, an infection, or a part that had moved, and problems after removal were uncommon. Because removal is another operation, most problems are worked through with settings and other treatment first.

Has Inspire been recalled?

One Inspire recall has been placed in the FDA’s most serious category, Class I. In 2024, 24 Inspire IV generators were recalled for a possible manufacturing defect that could cause an electrical fault and require surgery to replace the generator. Inspire’s other entries in the FDA recall database are Class II, for labeling errors on packaged parts. Your implanting team can check whether your device was affected.

What if Inspire wakes me up at night?

Tell your implanting team; it is not something to live with. The stimulation often feels stronger at first and becomes less noticeable over time, and the pulses do not reliably keep in step with breathing while you are awake. The pause button, a lower strength or a different electrode setting usually helps. Comfort matters, because people who find the stimulation uncomfortable tend to use the device less.

Should I trust online Inspire reviews?

Read them as one source among several. People with a problem are more likely to post, testimonials chosen by a manufacturer lean the other way, and neither shows the person’s sleep study, airway exam or settings. Published studies, a surgeon’s own results and the questions on this page give a more complete picture.

References

Each figure on this page was checked against the source named below. Where a study was industry-funded or industry-authored, it is labeled.

  1. Strollo PJ Jr, Soose RJ, Maurer JT, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014;370(2):139–149. doi:10.1056/NEJMoa1308659 — The STAR pivotal trial. Industry-funded and industry-conducted. 66% (83 of 126) met the success definition at 12 months; median AHI 29.3 to 9.0.
  2. Bentan MA, Dawood E, Moffatt D, Suurna MV, Nord R. Are there hidden adverse events in hypoglossal nerve stimulation: comparing social media and a federal database. Laryngoscope. 2024;134(12):5217–5222. doi:10.1002/lary.31589 — My research group’s study. Posts from October 2022 to October 2023 in three US Facebook groups for people with or considering Inspire: 132 problems in 737 posts, led by pain (34.85%), stimulation discomfort (14.39%), lower-lip weakness (6.82%), tongue weakness (4.55%), a tight lead in the neck (3.79%) and scarring (3.03%); compared with 428 FDA-reported events over the same year. The authors report no funding.
  3. Bentan MA, Nord R. Comprehensive analysis of adverse events associated with hypoglossal nerve stimulators: insights from the MAUDE database. Otolaryngol Head Neck Surg. 2024;171(5):1580–1590. doi:10.1002/ohn.883 — My research group’s analysis of 1,178 FDA reports filed May 2014 to December 2023, describing 1,312 events: infection 24.0%, pain 19.7%, hematoma or seroma 10.2%. Other categories included overstimulation, device migration, erosion or extrusion through the skin, lead tethering and sensing-lead malfunction. 83.1% needed medical or surgical treatment, most often removal (29.4%) or repositioning (15.8%). Three events described overstimulation during MRI.
  4. Bellamkonda N, Shiba T, Mendelsohn AH. Adverse events in hypoglossal nerve stimulator implantation: 5-year analysis of the FDA MAUDE database. Otolaryngol Head Neck Surg. 2021;164(2):443–447. doi:10.1177/0194599820960069 — Describes MAUDE as a publicly available, voluntary reporting system; 132 reports from 2014 to 2019.
  5. U.S. Food and Drug Administration. Medical device recall Z-2159-2024, Class I: Inspire Model 3028 (Inspire IV) implantable pulse generator. Initiated May 16, 2024; classified June 21, 2024; 24 devices. FDA Medical Device Recalls database entry · FDA recall record (openFDA data) · all Inspire Medical Systems entries (openFDA data) — Reason as recorded: a potential manufacturing defect that can lead to electrical leakage in the sensing circuit, causing a system malfunction that requires revision surgery to replace the generator. Firm-initiated. The firm’s notice asked clinicians to check affected devices with waveform and impedance testing and to watch for variation in stimulation, a lack of therapy effectiveness, or an inability to turn on therapy. The five other entries are Class II labeling corrections on packaged parts (2018, 2024 and 2026).
  6. Huyett P, Suurna MV. Lateral axillary approach for placement of the … hypoglossal nerve stimulator implantable pulse generator. Otolaryngol Head Neck Surg. 2025;173(3):778–781. doi:10.1002/ohn.1321 — The only peer-reviewed publication on Inspire V; documents that the generator internalizes the respiratory sensor, and reports technique rather than outcomes.
  7. Meleca JB, Kominsky AH. Reconfiguration of upper airway stimulation devices utilizing awake endoscopy. Laryngoscope. 2020;130(10):2494–2498. doi:10.1002/lary.28569 — Cleveland Clinic, 60 patients implanted 2015–2018: 24 awake endoscopies in 19 patients (32%), most often for stimulation discomfort (42%), frequent awakenings (32%), or persistent fatigue or AHI (21%). After the first, the functional threshold fell 53% and the minimum therapeutic amplitude 45%.
  8. Kant E, Hardeman JA, Stokroos RJ, Copper MP. Exploring the role of drug-induced sleep endoscopy in optimizing upper airway stimulation therapy for non-responders. Sleep Breath. 2025;29(5):285. doi:10.1007/s11325-025-03468-z · Free full text — Sint Antonius Hospital, the Netherlands: 29 non-responders among 114 implanted, 2015–2022. With the device on, the palate did not move with the tongue in 16 of 25 recorded. 6 were managed with new settings and 14 with added treatment (oral appliance, barbed pharyngoplasty or other airway surgery); AHI 41.6 to 23.2; 8 additional responders. The authors declare no conflicts.
  9. Soose RJ, Araujo M, Faber K, et al. Cluster analysis of upper airway stimulation adherence patterns and implications on clinical care. Sleep. 2022;45(11):zsac049. doi:10.1093/sleep/zsac049 — Industry-authored: two authors are Inspire Medical Systems employees. Device data from the first three months in 2,098 patients; 85% averaged more than 6 hours of use a night.
  10. Suurna MV, Steffen A, Boon M, et al. Impact of body mass index and discomfort on upper airway stimulation: ADHERE registry 2020 update. Laryngoscope. 2021;131(11):2616–2624. doi:10.1002/lary.29755 — Industry-sponsored registry: Inspire Medical Systems is the lead sponsor (ClinicalTrials.gov NCT02907398). Nightly use 4.9 versus 5.7 hours with and without discomfort; final AHI 18.9 versus 13.5. Success 72.2% with BMI 32 or less versus 59.8% with BMI over 32 up to 35.
  11. Kaffenberger TM, Sina EM, Hambach B, Kaki P, Fuleihan A, Boon M, Huntley C. How we measure hypoglossal nerve stimulator outcome matters: titration vs single amplitude efficacy sleep studies. J Clin Sleep Med. 2025;21(1):47–53. doi:10.5664/jcsm.11328 · Free full text — 61 patients tested both ways: success 80% on the in-lab titration study versus 46% on the all-night home study, under the under-15 definition.
  12. Coca KK, Heiser C, Huntley C, Boon M, de Vries N, Mamidala M, Gillespie MB. Hypoglossal nerve stimulation usage by therapy nonresponders. Otolaryngol Head Neck Surg. 2022;166(4):786–790. doi:10.1177/01945998211036867 — Industry-sponsored registry: data from ADHERE, sponsored by Inspire Medical Systems (ClinicalTrials.gov NCT02907398); five authors are ADHERE investigators. 717 patients at 12 months: 497 responders (69%) and 220 nonresponders (31%) by the Sher criteria; quality of life improved in 96% and 77%. Nightly use fell between the titration visit and 12 months in both groups, more in nonresponders (16%) than responders (8%).
  13. Soose RJ, Faber K, Greenberg H, Boon M, Woodson T, Strollo P. Post-implant care pathway: lessons learned and recommendations after 5 years of clinical implementation of hypoglossal nerve stimulation therapy. Sleep. 2021;44(Suppl 1):S4–S10. doi:10.1093/sleep/zsaa279 — Expert review. Several authors report research support or consulting ties to Inspire Medical Systems.
  14. Chu Z, Zhang C, Kwok E, et al. Hypoglossal nerve stimulation explantation in patients with obstructive sleep apnoea: a systematic review. J Laryngol Otol. 2025;139(8):655–662. doi:10.1017/S0022215124001646 — 14 studies, 121 patients, 126 reasons for removal: device malfunction 19.8%, infection 19.0%, migration 18.3%, discomfort 9.5%, improper placement 6.3%, ineffective device 6.3%. Complications after removal 2.48%.

Disclosures

I consulted for Inspire Medical Systems until 2025 and consult for AvivoMed. I have received research support from Nyxoah, the maker of Genio, and have been a paid member of the clinical events committee for Nyxoah-sponsored trials. Full disclosures are on my disclosures page.

No manufacturer reviewed, funded, or contributed to this page. Where a study cited here was industry-funded or industry-authored, it is labeled.

Try “success rate”, “BMI”, “Medicare”, “battery”, or “concentric collapse”.